Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis

被引：0
|
作者：
Erfan Taherifard
Muhammad Bakhtiar
Mahnoor Mahnoor
Rabeea Ahmed
Ludimila Cavalcante
Janie Zhang
Anwaar Saeed
机构：
[1] University of Pittsburgh Medical Center,Department of Medicine, Division of Hematology & Oncology
[2] Novant Health Cancer Institute,undefined
[3] UPMC Hillman Cancer Center,undefined
来源：
BMC Cancer | / 24卷
关键词：
Neuroendocrine tumors; Pancreatic neoplasms; Temozolomide; Response evaluation criteria in solid tumors; Drug-related side effects; Adverse reactions;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis
    Taherifard, Erfan
    Bakhtiar, Muhammad
    Mahnoor, Mahnoor
    Ahmed, Rabeea
    Cavalcante, Ludimila
    Zhang, Janie
    Saeed, Anwaar
    BMC CANCER, 2024, 24 (01)
  • [2] Efficacy and Safety of EUS-RFA in Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
    Moond, Vishali
    Bidani, Khyati
    Pannu, Jiteshwar S.
    Harne, Prateek
    Subramanian, Sruthi
    Mohan, Babu
    Thosani, Nirav
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1131 - S1132
  • [3] Temozolomide-based combination for advanced neuroendocrine neoplasms: a systematic review of the literature
    Abdel-Rahman, Omar
    Fouad, Mona
    FUTURE ONCOLOGY, 2015, 11 (08) : 1275 - 1290
  • [4] Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis
    Cigrovski Berkovic, Maja
    Coppola, Alessandro
    Sesa, Vibor
    Mrzljak, Anna
    Lai, Quirino
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (07) : 759 - 769
  • [5] Efficacy and safety between temozolomide alone and temozolomide-based double therapy for malignant melanoma: a meta-analysis
    Jiang, Guan
    Li, Rong-Hua
    Sun, Chao
    Jia, Hai-Yan
    Lei, Tie-Chi
    Liu, Yan-Qun
    TUMOR BIOLOGY, 2014, 35 (01) : 315 - 322
  • [6] Safety and efficacy of combination of temozolomide and pazopanib in patients with advanced pancreatic neuroendocrine tumors (PNET).
    Nimeiri, Halla Sayed
    Pai, Sachin Gopalkrishn
    Chiorean, E. Gabriela
    Rademaker, Alfred
    Kircher, Sheetal Mehta
    Mulcahy, Mary Frances
    Cohen, Steven J.
    Denlinger, Crystal Shereen
    Sahai, Vaibhav
    Zalupski, Mark
    Berlin, Jordan
    Benson, Al Bowen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Efficacy and Safety of Daratumumab Based Regimens for Multiple Myeloma: A Systematic Review and Meta-Analysis
    Abu Zar, Muhammad
    Kamal, Ahmad
    Khan, Ali Younas
    Malik, Saad Ullah
    Malik, Mustafa Nadeem
    Rafae, Abdul
    Durer, Ceren
    Durer, Seren
    Selene, Insija Ilyas
    Qureshi, Anum
    Jose, Jemin Aby
    Fazeel, Hafiz Muhammad
    Shah, Zunairah
    Rehman, Muhammad Adil
    Anwer, Faiz
    BLOOD, 2018, 132
  • [8] Efficacy and toxicity of surufatinib in neuroendocrine tumors: A systematic review and meta-analysis
    Ali, Muhammad Ashar
    Shah, Syed S.
    Tahir, Nayha
    Rehman, Sana
    Saeed, Memoona
    Bajwa, Shammas Farooq
    Ali, Rimsha
    Aiman, Wajeeha
    Anwar, Muhammad Yasir
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 (07)
  • [9] Safety and efficacy of combining capecitabine and temozolomide (CAPTEM) to treat advanced neuroendocrine neoplasms A meta-analysis
    Lu, Yaoheng
    Zhao, Zhicheng
    Wang, Ji
    Lv, Wenhao
    Lu, Li
    Fu, Weihua
    Li, Weidong
    MEDICINE, 2018, 97 (41)
  • [10] Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis
    Gillian K Gresham
    George A Wells
    Sharlene Gill
    Christopher Cameron
    Derek J Jonker
    BMC Cancer, 14
12345